BioQ Pharma Incorporated v. GS Holding
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 BIOQ PHARMA INCORPORATED, Case No. 23-cv-00399-AMO
8 Plaintiff,
ORDER RE MOTION FOR DEFAULT
9 v. AND MOTION TO SET ASIDE
DEFAULT
10 STAR CAPITAL INVESTMENTS LLC, et al., Re: Dkt. Nos. 16, 18 11 Defendants.
12 13 Before the Court are Plaintiff BioQ Pharma Incorporated’s Motion for Entry of Default or, 14 in the Alternative, to Permit Alternative Service filed by (ECF 16) and a Motion to Set Aside 15 Default filed by Defendants GS Holding and Star Capital Investments LLC (ECF 18). The 16 motions are fully briefed and suitable for decision without oral argument. Accordingly, the 17 hearing set for January 18, 2024, is VACATED. See Civil L.R. 7-6. Having read the parties’ 18 papers and carefully considered their arguments and the relevant legal authority, and good cause 19 appearing, the Court hereby GRANTS Defendants’ motion to set aside default, DENIES as moot 20 Plaintiff’s motion for default, and DENIES without prejudice Plaintiff’s motion for…